- Home
- Publications
- Publication Search
- Publication Details
Title
Research Trends and Regulation of CCL5 in Prostate Cancer
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 14, Issue -, Pages 1417-1427
Publisher
Informa UK Limited
Online
2021-02-25
DOI
10.2147/ott.s279189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling
- (2020) Renlun Huang et al. Cell Death & Disease
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling
- (2019) Peng Xiang et al. PROSTATE
- Pharmacological effects and potential therapeutic targets of DT-13
- (2018) Ghulam Jilany Khan et al. BIOMEDICINE & PHARMACOTHERAPY
- C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment
- (2018) Satoko Urata et al. CANCER SCIENCE
- Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
- (2018) Donatella Aldinucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Endothelial cells promote metastasis of prostate cancer by enhancing autophagy
- (2018) Ruizhe Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Triggering TLR3 pathway promotes tumor growth and cisplatin resistance in head and neck cancer cells
- (2018) Hui-Ching Chuang et al. ORAL ONCOLOGY
- DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
- (2018) Zhengming Wang et al. Frontiers in Pharmacology
- Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV
- (2017) Yi Zheng et al. IMMUNITY
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells
- (2017) Hongyang Li et al. Cell Death & Disease
- Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
- (2016) Niels Halama et al. CANCER CELL
- Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling
- (2016) Shu Tang et al. CANCER LETTERS
- Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
- (2016) BO ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment
- (2016) Chiuan-Ren Yeh et al. Molecular Cancer
- Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo
- (2016) Xiao-Wen Yu et al. Oncotarget
- Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis
- (2016) Aerken Maolake et al. Oncotarget
- PI3K signalling in inflammation
- (2015) P.T. Hawkins et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Exploration on natural product anibamine side chain modification toward development of novel CCR5 antagonists and potential anti-prostate cancer agents
- (2015) Guoyan G. Xu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tumor-Induced Pressure in the Bone Microenvironment Causes Osteocytes to Promote the Growth of Prostate Cancer Bone Metastases
- (2015) Joseph L. Sottnik et al. CANCER RESEARCH
- Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals
- (2015) Jie Luo et al. Oncotarget
- CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
- (2015) Haixia Long et al. Oncotarget
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- CCR5 Receptor Antagonists Block Metastasis to Bone of v-Src Oncogene-Transformed Metastatic Prostate Cancer Cell Lines
- (2014) D. Sicoli et al. CANCER RESEARCH
- The potential to target CCL5/CCR5 in breast cancer
- (2014) Marco Velasco-Velázquez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Roles for Chemokines in Liver Disease
- (2014) Fabio Marra et al. GASTROENTEROLOGY
- The Metastasis Suppressor, N-myc Downstream-regulated Gene 1 (NDRG1), Inhibits Stress-induced Autophagy in Cancer Cells
- (2014) Sumit Sahni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Inflammatory Chemokine CCL5 and Cancer Progression
- (2014) Donatella Aldinucci et al. MEDIATORS OF INFLAMMATION
- CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
- (2014) Igor Tsaur et al. Cancer Research and Treatment
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- Chemokines and Chemokine Receptors as Promoters of Prostate Cancer Growth and Progression
- (2013) Nicole Salazar et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling
- (2013) Taku Kato et al. CYTOKINE
- Targeting CCL5 in inflammation
- (2013) Rafael Elias Marques et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling
- (2013) J Luo et al. ONCOGENE
- CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
- (2012) A. Tsuyada et al. CANCER RESEARCH
- JNK-Induced Apoptosis, Compensatory Growth, and Cancer Stem Cells
- (2012) F. Chen CANCER RESEARCH
- Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents
- (2012) Feng Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CCR5 inhibitors: emergence, success, and challenges
- (2012) Kenji Maeda et al. EXPERT OPINION ON EMERGING DRUGS
- Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity
- (2012) Cinzia Borghese et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
- (2012) E. H. Yi et al. MOLECULAR CANCER RESEARCH
- CCL5 and CCR5 Interaction Promotes Cell Motility in Human Osteosarcoma
- (2012) Shih-Wei Wang et al. PLoS One
- CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer
- (2012) Manisha Agarwal et al. PROSTATE
- Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133+Ovarian Cancer Stem-Like Cells via NF-κB-Mediated MMP-9 Upregulation
- (2012) Haixia Long et al. STEM CELLS
- The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents
- (2011) Kendra M. Haney et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES Is Consistently Increased
- (2011) R. M. Gonzalez et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior
- (2011) G Gueron et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents
- (2010) Xueping Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection
- (2010) Jennifer L Gregg et al. BMC CANCER
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes
- (2009) H. Laubli et al. BLOOD
- Epithelial-Mesenchymal Transition and Cell Cooperativity in Metastasis
- (2009) T. Tsuji et al. CANCER RESEARCH
- LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression
- (2009) Ja Eun Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of the chemokines CCL3/MIP-1α and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice
- (2009) Lucíola S. Barcelos et al. MICROVASCULAR RESEARCH
- The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1
- (2009) Marco Colombatti et al. PLoS One
- CCL5 increases lung cancer migration via PI3K, Akt and NF-κB pathways
- (2008) Chun-Yin Huang et al. BIOCHEMICAL PHARMACOLOGY
- The inflammatory chemokines CCL2 and CCL5 in breast cancer
- (2008) Gali Soria et al. CANCER LETTERS
- Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis
- (2008) S.-Y. Sung et al. CANCER RESEARCH
- Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer
- (2008) Hidekazu Sugasawa et al. JOURNAL OF SURGICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started